320 related articles for article (PubMed ID: 35080656)
1. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
[TBL] [Abstract][Full Text] [Related]
2. Using Mendelian randomization study to assess the renal effects of antihypertensive drugs.
Zhao JV; Schooling CM
BMC Med; 2021 Mar; 19(1):79. PubMed ID: 33766008
[TBL] [Abstract][Full Text] [Related]
3. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
Fan B; Zhao JV
BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
[TBL] [Abstract][Full Text] [Related]
4. Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.
Wang Z; Lu J; Hu J
Liver Int; 2023 Jun; 43(6):1320-1331. PubMed ID: 37005366
[TBL] [Abstract][Full Text] [Related]
5. The Associations of Genetically Predicted Plasma Alanine with Coronary Artery Disease and its Risk Factors: A Mendelian Randomization Study.
Huang X; Zhao JV
Am J Clin Nutr; 2023 Nov; 118(5):1020-1028. PubMed ID: 37640107
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Traits and Stroke Risk in Individuals of African Ancestry: Mendelian Randomization Analysis.
Fatumo S; Karhunen V; Chikowore T; Sounkou T; Udosen B; Ezenwa C; Nakabuye M; Soremekun O; Daghlas I; Ryan DK; Taylor A; Mason AM; Damrauer SM; Vujkovic M; Keene KL; Fornage M; Järvelin MR; Burgess S; Gill D
Stroke; 2021 Aug; 52(8):2680-2684. PubMed ID: 34078102
[TBL] [Abstract][Full Text] [Related]
7. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
8. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
[TBL] [Abstract][Full Text] [Related]
10. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
11. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.
Au Yeung SL; Luo S; Schooling CM
Diabetologia; 2019 Sep; 62(9):1638-1646. PubMed ID: 31161347
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
13. The risk of common hypoglycemic and antihypertensive medications and COVID-19: A 2-sample Mendelian randomization study.
Wang Y; Li K; Zeng J; Lu S; Deng W
Medicine (Baltimore); 2024 Feb; 103(6):e36423. PubMed ID: 38335406
[TBL] [Abstract][Full Text] [Related]
14. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study.
Xu L; Borges MC; Hemani G; Lawlor DA
Diabetologia; 2017 Nov; 60(11):2210-2220. PubMed ID: 28889241
[TBL] [Abstract][Full Text] [Related]
15. Lipids, Blood Pressure, and Diabetes Mellitus on Risk of Cardiovascular Diseases in East Asians: A Mendelian Randomization Study.
Ciofani JL; Han D; Allahwala UK; Woolf B; Gill D; Bhindi R
Am J Cardiol; 2023 Oct; 205():329-337. PubMed ID: 37633070
[TBL] [Abstract][Full Text] [Related]
16. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
17. Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.
Allara E; Morani G; Carter P; Gkatzionis A; Zuber V; Foley CN; Rees JMB; Mason AM; Bell S; Gill D; Lindström S; Butterworth AS; Di Angelantonio E; Peters J; Burgess S;
Circ Genom Precis Med; 2019 Dec; 12(12):e002711. PubMed ID: 31756303
[TBL] [Abstract][Full Text] [Related]
18. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
19. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
20. Lean mass, grip strength and risk of type 2 diabetes: a bi-directional Mendelian randomisation study.
Yeung CHC; Au Yeung SL; Fong SSM; Schooling CM
Diabetologia; 2019 May; 62(5):789-799. PubMed ID: 30798333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
